医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2025年澳大利亚和新西兰血液学年会(BLOOD 2025)
     
 

◆ 会议时间:2025年10月26-29日
◆ 会议地点:澳大利亚 珀斯

 

◆ 会议简介:

2025年澳大利亚和新西兰血液学年会(BLOOD2025)暨36届国际输血协会(ISBT)区域大会将于2025年10月26-29日在澳大利亚珀斯举行,BLOOD 2025是澳大利亚和新西兰血液学会(HSANZ)、澳大利亚和新西兰输血协会(ANZSBT)、澳大利亚和新西兰血栓与止血学会(THANZ)三家机构的联合年会。

澳大利亚和新西兰血液学学会(HSANZ)于1998年由澳大利亚血液学会和新西兰血液学会合并组建而成。HSANZ的目标是:促进、培养和发展血液学学科的各方面;为血液学研究提供支持和倡导;促进卓越并倡导改善血液病患者的护理;鼓励、激发和宣促进医学和护理专业人员、科学家和更广泛的社区对血液学的教育和兴趣;为血液学家、科学家、护士、学生和其他有关方面提供机会,以促进血液学领域的科学交流和教育;促进血液学研究和实践方面的国家和国际层面的合作。

澳大利亚和新西兰输血协会(ANZSBT) 前身为澳大利亚输血学会(ASBT),2002年底更为现名。ANZSBT由来自不同科学、技术和医学背景的成员组成,他们在澳大利亚和新西兰的输血和输血医学领域工作。ANZSBT的宗旨是在输血医学中提供和传播独立的专业知识;定义和促进临床和实验室输血医学的最佳实践;通过沟通、代表和宣传,与所有领域的利益相关者进行联系;促进和支持教育和研究工作。

澳大利亚和新西兰血栓与止血学会(THANZ)是一个汇集各种与出血、血栓形成和同源领域有关学科的论坛,代表了近300名临床医生和科学家。THANZ的宗旨是为凝血和出血障碍患者的提供卓越的临床护理; 领导科学家和临床医生在该领域的教育和培训;通过研究、发现和临床试验促进创新;倡导和制定改善健康结果的政策。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

Blood 2025 - the combined Annual Scientific Meeting of the:

  • Haematology Society of Australia and New Zealand
  • Australian and New Zealand Society of Blood Transfusion
  • Thrombosis and Haemostasis society of Australia and New Zealand

ISBT Perth - 36th Regional Congress of the:

  • International Society of Blood Transfusion

Dates:
26 - 29 October 2025

Venue:
Perth Convention and Exhibition Centre (PCEC) 
Perth, Australia


摘要征集-Call for Abstracts:

The deadline for abstract submissions is Thursday 1st May (no extensions will be allowed).

点此提交摘要>>>Submit Abstract>>>

 

You are invited to submit informative and relevant abstracts in a word document using the approved template and following all guidelines below:

  • All abstracts must be original work, submission acknowledges consent to publication of the abstract in the Meeting proceedings and Meeting app (approximately 1 week prior the Meeting).
  • All abstracts must be submitted in English, please do not rely on google translate. If you need assistance please contact us.
  • All Blood Transfusion accepted abstracts will be included in an abstract book that will be published by Vox Sanguinis (online only) and also made available on the ISBT congress website.
    • Every effort will be made to publish the abstract exactly as it was submitted. As abstracts will be typeset for electronic distribution and publication, they may be edited or corrected by the ISBT staff as needed to conform to publications style.
    • Whilst every effort will be made to ensure the reproduction of symbols, accuracy of symbols cannot be guaranteed in the reproduction
  • The presenting author will be required to register and pay for the Meeting in order to ensure their abstract(s) is included in the final program. Failure to register will result in withdrawal of the abstract. Presenting authors must register by 29 August 2025.
  • The presenting author must be listed as an author on the abstract during submission. If for any reason the nominated presenting author cannot attend, a replacement author can give the presentation but the replacement presenter must have been listed as an author during the original abstract submission and subject to approval by the Organising Committee. If no named authors are available to give the presentation, the abstract must be withdrawn.
  • You are not required to be a member of any of the Societies to submit an abstract, however membership is required for many of the Awards and Grants offered. Additional information to determine award eligibility, such as age at time of the Meeting and date of your last qualification, is required to be provided during submission if you wish to be considered for an award.
  • If your abstract has been previously presented, please ensure you disclose
    • where / when your material was presented or published during submission
    • if there has been and change since the last publication (if so you will need to summarise during submission)
  • Accuracy is the responsibility of the author, please ensure you have proof read your document carefully

HSANZ, THANZ, Nursing, BMTSAA
Abstract Guidelines

Your abstract must be prepared using this HSANZ, THANZ, Nursing, and BMBTSAA template

Please download this now and complete prior to starting your submission process. 

Please save the file using the first 5 words of your title as the file name, do not include any presenter or author's names in the file name or abstract document. You will upload this document as part of your abstract submission.

  • Abstract title: 
    • Sentence case (capitalising only the first word and proper nouns)
    • The title (including spaces) should not exceed 200 characters
    • Do NOT type a full stop (.) at the end of the title
    • The abstract title must not include product trade names
    • Do not use quotation marks
  • The Committee suggests that where applicable* the abstract should follow the format outlined below:
    • Aim
    • Method
    • Result
    • Conclusion
    • *Abstracts such as case studies, reviews or reports are welcomed and do not need to follow the heading as outlined above
  • Tables and figures can be included but the abstract must be laid out as specified and must not exceed one page.
  • Please only use standard abbreviations or define them in full.
  • Please use Arial font, size 11pt.
  • Please limit your abstract to 300 words (excluding titles and references)
  • Paragraphs should be separated by an empty line, please do not indent the first line of a paragraph

Blood Transfusion (ANZSBT / ISBT)
Abstract Guidelines

Your abstract must be prepared using the Blood Transfusion template

Please download this now and complete prior to starting your submission process. 

Please save the file using the first 5 words of your title as the file name, do not include any presenter or author's names in the file name or abstract document. You will upload this document as part of your abstract submission.

  • Abstract title:
    • Sentence case (capitalising only the first word and proper nouns)
    • The title (including spaces) should not exceed 200 characters
    • Do NOT type a full stop (.) at the end of the title
    • The abstract title must not include product trade names
  • The following format must be followed:
    • Background
    • Aims
    • Methods
    • Results
    • Summary / Conclusions
  • References: Including references and adding a reference list at the end of the abstract is not permitted. However, if it is necessary to refer to one or more specific publication(s), it is advised to cite these in the abstract text as follows: “Johnson, Vox Sang, 2015”.
  • Graphics, figures and pictures are not allowed
  • Tables: a maximum 1 table may be included in the body of the abstract. The maximum number of columns in the table is 5 and the maximum number of rows is 10
  • Lists: where an itemised list is used, please use bullet points (as in this list) rather than 1,2,3 or a,b,c etc.
  • The abstract text should be no more than 3500 characters (including characters in tables, not including spaces)
  • Please use Arial font, size 11pt
  • Language setting of your keyboard: the keyboard configuration of computers in non-Western countries can cause problems with the printing of the proceedings. To avoid these problems, you need to change the language setting of your computer
An international panel of experts will review the abstracts. An abstract may be selected for an oral or poster or may be rejected. 

Rejection criteria include: 

  • The content is not relevant to Transfusion Medicine 
  • No new or relevant work (viewed in the context of the HDI of the country) 
  • Data does not support conclusions 
  • Not in the format set out in these guidelines 
  • Not in English with an acceptable level of language 
  • Includes any confidential patient data 
  • Has been published in a PubMed listed journal or presented at another international meeting (unless new data/information is included) 
  • Contains commercial bias/advertising* 

 *If the abstract involves commercial products, it must be objective, be based on scientific methods and be free of commercial bias for or against any products. Generic names should be used whenever possible and trade names should not be included in the title. The intent is to avoid abstracts submitted for promotional purposes. 

Authors and Affiliations

Do not include the author's names in the body of the abstracts as the abstracts are subject to a blind review process. The names of all participating authors (including yourself) will be entered into the abstract submission form. Please do not include degrees or professional titles.

Abstract Theme

During submission, you will nominate a theme most relevant for your submission. Your abstract will be reviewed in your nominated category, however the Organisers reserve the right to move abstracts to different themes to best suit the program. 

The themes are:

  • Blood Transfusion (ANZSBT/ISBT)
    • Blood components and products
    • Blood donors and donation
    • Management, organisation and quality
    • Clinical transfusion
    • Immunohaematology
    • Transfusion transmitted infections
    • Other
  • BMTSAA
  • HSANZ
    • Acute leukaemia
    • BMT
    • CLL
    • CML
    • Lymphoma
    • MDS
    • MPD
    • Myeloma
    • Non-malignant
    • Supportive Care
  • Nursing
  • THANZ

Conflict of Interest Statement

If the research described in the abstract was supported by a commercial company you must indicate the company's role in analysing the data or preparing the abstract. You will be asked to supply the following statement during the submission process:

"No conflict of interest to disclose".

"This research was supported by __________. The company had no role in analysing the data or preparing the abstract."

"This research was supported by __________. The company insert free text describing company role in data analysis or abstract preparation."

This conflict-of-interest statement is mandatory for all abstracts submitted and where there is a conflict, this will appear wherever the abstracts are published. For abstracts accepted as an oral presentation, please ensure you include a slide disclosing the conflict of interest within your presentation.

You will also need to disclose if any authors (or their close family) are directors/owners of commercial companies in the field of haematology, transfusion medicine, thrombosis and haemostasis.

 


 

注册费:

Registration Fees

The fees vary depending on the date of registration, membership, and country of residence
  • Date: Early fees are available until 19 August 2025
  • Membership: We encourage you to become an ISBT member to benefit from lower registration fees
  • Country of residence: The current list of countries classified by income can be found on the World Bank Index (WBI) website.
Please note: Payments will be processed in Australian Dollars (AUD), include Goods and Services Tax of 10%, and are subject to current exchange rates and any applicable card or bank fees at the time of the transaction.

Prices listed in Euros (€) are estimates based on exchange rates at time of publication.

Full Registration
(membership rates open to ISBT, HSANZ, ANZSBT and THANZ members)

Early Fee (payment before 19 August 2025)

Standard Fee (payment after 19 August 2025)

Member* - High WBI Countries
A$950  (~€550)
A$1075 (~€620)
Non-member - High WBI Countries
A$1300 (~€750) A$1425 (~€825)
Member* - Upper Middle WBI Countries
A$830 (~€480) A$950 (~€550)
Non-Member - Upper Middle WBI Countries
A$1100 (~€635) A$1200 (~€695)
Member* - Lower Middle WBI Countries
A$610 (~€350) A$700 (~€405)
Non-Member - Lower Middle WBI Countries
A$670 (~€390) A$780 (~€450)
Member* -  Low WBI Countries
A$260 (~€150) A$350 (~€200)
Non-Member - Low WBI Countries
A$385 (~€225) A$520 (~€300)
Student**
A$400 (~€230) A$550 (~€320)

Corporate/Industry Registration ***



* Society Membership 
In order to register at the member rates offered, you must be a current financial member of ISBT (or HSANZANZSBTTHANZ). If you are not currently a member but would like to join to take advantage of the reduced registration fees as well as Society benefits, please contact the Societies for more information on the membership criteria and cost. 

** Student Registration
To qualify for the student rate, you must provide evidence that you are a full time student at the time of the Meeting. Accepted forms of evidence include a letter from the university registrar’s office confirming your enrolment status or an official transcript of the classes you are undertaking.

*** Corporate / Industry Registration
Corporate and Industry registrations are available on a limited basis and at the discretion of the Organisers. If you are a Corporate or Pharmaceutical representative interested in having a presence at Blood ISBT 2025, please consult the Sponsorship and Exhibition ProspectusIndustry Registration page.

Please note: In the interest of reducing fees Upper Middle, Lower Middle, and Low, WBI Countries along with students have the option reduce costs without a dinner ticket, choosing whether to purchase.

 

Function Tickets


Additional Welcome Reception ticket (one included per registration, additional tickets can be purchased for guests)
A$95 (~€55)
Gala Dinner delegate ticket (Students, Upper Middle, Lower Middle, and Low WBI Countries)
A$120 (~€70)
Gala Dinner guest ticket (additional tickets can be purchased for guests)
A$200 (~€115)

Full Registration Fee includes:

  • Access to all conference sessions Sunday 26 - Wednesday 29 October
  • Morning tea, lunches and afternoon teas as indicated in the program
  • Ticket to the Welcome Function, Sunday 26 October
  • Access to the Poster session on Monday 27 October
  • Access to exhibition
  • Name badge and conference materials

Publication of Abstracts
Registration is a prerequisite for publication of abstracts in final program. 

Terms & Conditions 

  • Full payment for registration fees must be received prior to Blood ISBT 2025.
  • All prices are in Australian dollars and include Goods and Services Tax of 10%.
  • If you did NOT tick ‘Privacy Required’ on the first page of the online registration form, it is assumed that you agree to have your details published in the list of participants. 

Cancellations: 

  • Should you need to cancel your registration for any reason, you may reassign your registration to another person. Please notify The Conference Company via email of the replacement delegate's name and contact details.
  • If you are unable to arrange a replacement, a refund less a cancellation fee of A$100 will be made, providing notification is received prior to 19 August 2025. Cancellations made after 19 August 2025 are non-refundable. 
  • If, for reasons beyond the control of the Organising Committee, the meeting is cancelled, registration fees will be refunded after the deduction of expenses already incurred.
  • By registering for the Meeting you are confirming consent for any video and photographs taken at the Meeting which you are in may be used by the Organising Committee in promotion of the Meeting.

 

◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1650元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们